References
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009;113:S1–130
- D'Amour P, Labelle F, Lecavalier L, Plourde V, Harvey D. Influence of serum Ca concentration on circulating molecular forms of PTH in three species. Am J Physiol 1986;241: E680–7.
- Brossard JH, Cloutier M, Roy L, Lepage R, Gascon-Barre M, D'Amour P. Accumulation of a non-(1-84) molecular form detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. J Clin Endocrinol Metab 1996;81:3923–9.
- D'Amour P, Palardy J, Bashali G, Mallette LE, DeLean A, Lepage R. Modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration. J Clin Endocrinol Metab 1992;75:525–32.
- Freitag J, Martin K, Huruska K, Anderson C, Conrades M, Ladenson J, Klahr S, Slatopolsky E. Impaired parathyroid hormone metabolism in patients with chronic renal failure. N Engl J Med 1978;298:29–32.
- Ureña Torres P. The need for reliable serum parathyroid hormone measurements. Kidney Int 2006;70:240–3.
- Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, D'Amour P. A non-(1-84) PTH circulating fragment interferes significantly with intact PTH measurement by commercial assays in uremic samples. Clin Chem 1998; 44:805–9.
- Cantor T, Yang Z, Caraiani N, Ilamathi E. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions. Clin Chem 2006;52: 1771–6.
- Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–10.
- D'Amour P, Brossard JH, Rakel A, Rousseau L, Albert C, Cantor T. Evidence that the amino-terminal composition of non-(1-84) parathyroid hormone fragments starts before position 19. Clin Chem 2005;51:169–76.
- Souberbielle JC, Boutten A, Carlier MC, Chevenne D, Coumaros G, Lawson-Body E, Massart C, Mange M, Myara J, Parent X, Plouvier E, Houillier P. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 2006;70:345–50.
- Hamdy NA, Kanis JA, Beneton MN, Brown CB, Juttmann JR, Jordans JG, Josse S, Meyrier A, Lins RL, Fairey IT. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 1995;310:358–63.
- Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoune T. Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 1999;33:287–93.
- John MR, Goodman WG, Gao P, Cantor T, Salusky IB, Jüppner H. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure. J Clin Endocrino Metab 1999;84:4287–90.
- Reichel H, Esser A, Roth HJ, Schmidt-Gayk H. Influence of PTH assay methodology on differential diagnosis of renal bone disease. Nephrol Dial Transplant 2003;18:759–68.
- Estepa JC, Lopez I, Felsenfeld AJ, Gao P, Cantor T, Roriguez M, Aguilera-Tejero E. Dynamics of secretion and metabolism of PTH during hypo- and hypercalcaemia in the dog as determined by the ‘intact’ and ‘whole’ PTH assays. Nephrol Dial Transplant 2003;18:1101–7.
- Gao, P, Scheibel S, D'Amour P, John MR, Rao SD, Schmidt-Gayk H, Cantor T. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implication for improvement of accurate assessment of parathyroid function. J Bone Miner Res 2001;16:605–14.
- Monier-Faugère MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor T, Malluche HH. Improved assessment of bone turnover by the PTH (1–84)/C-PTH fragments ratio in ESRD patients. Kidney Int 2001;60:460–8.
- Tanaka M, Komaba H, Itoh K, Matsushita K, Matsushita K, Hamada Y, Fujii H, Fukagawa M. The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism. Nephrol Dial Transplant 2008; 1:iii59–62.
- Ljungdahl N, Haarhaus M, Linder C, Magnusson P. Comparison of 3 third-generation assays for bio-intact parathyroid hormone. Clin Chem 2006;52:903–4.